Earnings
INM
3.580
-1.92%
-0.070
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-06-30
5.82M
42.52K
--
45.48K
--
--
0.00
--
--
--
420.25K
--
6.33M
404.76K
--
--
--
--
803.56K
--
--
1.21M
7.54M
--
1.61M
0.00
--
--
--
--
--
--
--
--
--
--
1.68M
248.79K
--
--
--
--
248.79K
1.93M
50.48M
11.39M
-56.26M
--
--
--
5.61M
5.61M
7.54M
FY 2020-06-30
5.81M
42.38K
--
45.34K
--
--
0.00
--
--
--
418.92K
--
6.31M
403.49K
--
--
--
--
1.09M
--
0.00
1.49M
7.80M
--
1.61M
0.00
--
--
--
--
--
--
--
--
--
--
1.68M
248.01K
--
--
--
0.00
248.01K
1.92M
53.07M
17.76M
-64.65M
--
--
--
5.88M
5.88M
7.80M
FY 2019-06-30
9.80M
3.93M
--
64.71K
--
--
0.00
--
--
--
323.05K
--
14.12M
42.51K
--
--
--
--
902.05K
--
--
944.55K
15.07M
--
1.19M
0.00
--
--
--
--
--
--
--
--
--
--
1.19M
0.00
--
--
--
--
0.00
1.19M
52.22M
10.82M
-49.16M
--
--
--
13.88M
13.88M
15.07M
FY 2019-06-30
10.31M
4.14M
--
68.08K
--
--
0.00
--
--
--
339.86K
--
14.86M
44.72K
--
--
--
--
948.99K
--
--
993.71K
15.85M
--
1.25M
0.00
--
--
--
--
--
--
--
--
--
--
1.25M
0.00
--
--
--
--
0.00
1.25M
54.93M
11.39M
-51.72M
--
--
--
14.60M
14.60M
15.85M
FY 2018-06-30
18.37M
1.78M
--
40.63K
--
--
0.00
--
--
--
154.89K
--
20.35M
42.42K
--
--
--
--
969.52K
--
--
1.01M
21.36M
--
713.82K
0.00
--
--
--
--
--
--
--
--
--
--
713.82K
0.00
--
--
--
--
0.00
713.82K
51.81M
7.90M
-39.06M
--
--
--
20.65M
20.65M
21.36M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out INM latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze InMed Pharmaceuticals Inc. recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.